Mustang Bio Statistics

Total Valuation

Mustang Bio has a market cap or net worth of $3.73 million. The enterprise value is -$2.23 million.

Market Cap	3.73M
Enterprise Value	-2.23M

Important Dates

The next estimated earnings date is Tuesday, May 20, 2025, after market close.

Earnings Date	May 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Mustang Bio has 3.30 million shares outstanding. The number of shares has increased by 254.41% in one year.

Current Share Class	2.46M
Shares Outstanding	3.30M
Shares Change (YoY)	+254.41%
Shares Change (QoQ)	+37.29%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	3.62%
Float	2.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-0.96
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.68

Current Ratio	0.68
Quick Ratio	0.57
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,510.60

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-58.01%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	380.28%
Revenue Per Employee	n/a
Profits Per Employee	-$2.63M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.31% in the last 52 weeks. The beta is 2.27, so Mustang Bio's price volatility has been higher than the market average.

Beta (5Y)	2.27
52-Week Price Change	-91.31%
50-Day Moving Average	1.34
200-Day Moving Average	8.41
Relative Strength Index (RSI)	37.07
Average Volume (20 Days)	1,078,364

Short Selling Information

The latest short interest is 199,322, so 6.03% of the outstanding shares have been sold short.

Short Interest	199,322
Short Previous Month	60,740
Short % of Shares Out	6.03%
Short % of Float	9.61%
Short Ratio (days to cover)	0.21

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.55M
Pretax Income	-40.10M
Net Income	-15.75M
EBITDA	-11.88M
EBIT	-12.55M
Earnings Per Share (EPS)	-$25.84

Full Income Statement

Balance Sheet

The company has $6.84 million in cash and $878,000 in debt, giving a net cash position of $5.96 million or $1.80 per share.

Cash & Cash Equivalents	6.84M
Total Debt	878,000
Net Cash	5.96M
Net Cash Per Share	$1.80
Equity (Book Value)	-3.87M
Book Value Per Share	-2.12
Working Capital	-4.00M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11.41M
Capital Expenditures	n/a
Free Cash Flow	-11.41M
FCF Per Share	-$3.45

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mustang Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-254.41%
Shareholder Yield	-254.41%
Earnings Yield	-421.85%
FCF Yield	-305.57%

Analyst Forecast

The average price target for Mustang Bio is $100.00, which is 8,749.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$100.00
Price Target Difference	8,749.56%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 16, 2025. It was a reverse split with a ratio of 0.02:1.

Last Split Date	Jan 16, 2025
Split Type	Reverse
Split Ratio	0.02:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1